Method
Level · gp.fundamentals.debt_to_revenue
Raw value 461.69% · OPTIONAL
· Surgical & Medical Instruments & Apparatus
RESEARCH SNAPSHOTClearPoint Neuro, Inc.'s latest supported as-filed period reports revenue of $10.9M. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.debt_to_revenue
Raw value 461.69% · OPTIONAL
Level · gp.fundamentals.capex_revenue_ratio
Raw value 1.97% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value -64.48% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value 18.07% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 81.00% · OPTIONAL
Level · gp.fundamentals.gross_margin
Raw value 61.67% · CORE
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
This cluster groups 2 independently calculated changes: Cash & equivalents decreased 29.3%; Operating cash flow decreased 174.9%.
2 evidence-backed componentsThis cluster groups 2 independently calculated changes: Inventory increased 40.0%; Inventory / revenue moved 1271 bp higher.
2 evidence-backed componentsThis cluster groups 3 independently calculated changes: Revenue increased 18.1%; Operating margin moved 3252 bp lower; Operating income decreased 80.4%.
3 evidence-backed componentsThis cluster groups 2 independently calculated changes: Capital expenditure increased 135.2%; Capex / revenue moved 98 bp higher.
2 evidence-backed componentsFree-cash-flow proxy changed -173.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
CLPT · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001193125-26-382208SEC ↗10-QAug 3, 2026Period Jun 30, 20260001193125-26-330842SEC ↗8-KAug 3, 2026Period Aug 3, 20260001193125-26-330541SEC ↗4Jul 6, 2026Period Jul 1, 20260001193125-26-296615SEC ↗4Jul 6, 2026Period Jul 1, 20260001193125-26-296614SEC ↗4Jul 2, 2026Period Jun 30, 20260001193125-26-294477SEC ↗4Jul 2, 2026Period Jun 30, 20260001193125-26-294476SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Sep 2, 2026Filed Sep 3, 2026 | BURNETT JOSEPHCEO and President | Option ExerciseDirect | 12,517 | $3 | $43,434 | Form 4 ↗ |
| Sep 2, 2026Filed Sep 3, 2026 | BURNETT JOSEPHCEO and President | Option ExerciseDirect | 12,517 | $0 | $0 | Form 4 ↗ |
| Jul 1, 2026Filed Jul 6, 2026 | FLETCHER R JOHNDirector | Grant Or AwardDirect | 662 | $18 | $11,810 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Level · gp.fundamentals.operating_margin
Raw value -94.15% · CORE
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Raw value 42.57% · OPTIONAL
Level · gp.fundamentals.sbc_revenue_ratio
Raw value 20.87% · OPTIONAL
Operating cash flow changed -174.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current liabilities changed +39.4% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Inventory changed +40.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Working capital / assets changed -2959 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Gross debt changed +74.1% from the comparable as-filed period. The change ranks at the 80th percentile of 5 prior comparable changes.
Reported total debt changed +74.1% from the comparable as-filed period. The change ranks at the 80th percentile of 5 prior comparable changes.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001193125-26-294474